458 related articles for article (PubMed ID: 12392035)
1. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators in chronic obstructive pulmonary disease.
Chung KF
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):619-25. PubMed ID: 17305518
[TBL] [Abstract][Full Text] [Related]
3. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
Jeffery PK
Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
[TBL] [Abstract][Full Text] [Related]
5. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
6. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
7. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma.
Stankiewicz W; Dabrowski MP; Chcialowski A; Plusa T
Mediators Inflamm; 2002 Oct; 11(5):307-12. PubMed ID: 12467523
[TBL] [Abstract][Full Text] [Related]
8. Cytokines as targets in chronic obstructive pulmonary disease.
Chung KF
Curr Drug Targets; 2006 Jun; 7(6):675-81. PubMed ID: 16787167
[TBL] [Abstract][Full Text] [Related]
9. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
10. Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis.
Sastre B; Fernández-Nieto M; Mollá R; López E; Lahoz C; Sastre J; del Pozo V; Quirce S
Allergy; 2008 Jan; 63(1):58-66. PubMed ID: 17961198
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I)].
Mróz RM; Szulakowski P; Pierzchala W; Chyczewska E; MacNee W
Wiad Lek; 2006; 59(1-2):92-6. PubMed ID: 16646301
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.
de Boer WI; Sont JK; van Schadewijk A; Stolk J; van Krieken JH; Hiemstra PS
J Pathol; 2000 Apr; 190(5):619-26. PubMed ID: 10727989
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.
Oudijk EJ; Nijhuis EH; Zwank MD; van de Graaf EA; Mager HJ; Coffer PJ; Lammers JW; Koenderman L
Thorax; 2005 Jul; 60(7):538-44. PubMed ID: 15994259
[TBL] [Abstract][Full Text] [Related]
14. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
15. Differences and similarities between chronic obstructive pulmonary disease and asthma.
Jeffery PK
Clin Exp Allergy; 1999 Jun; 29 Suppl 2():14-26. PubMed ID: 10421818
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays.
Jarai G; Sukkar M; Garrett S; Duroudier N; Westwick J; Adcock I; Chung KF
Eur J Pharmacol; 2004 Aug; 497(3):255-65. PubMed ID: 15336943
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
18. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.
Molet S; Hamid Q; Davoine F; Nutku E; Taha R; Pagé N; Olivenstein R; Elias J; Chakir J
J Allergy Clin Immunol; 2001 Sep; 108(3):430-8. PubMed ID: 11544464
[TBL] [Abstract][Full Text] [Related]
19. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.
Moermans C; Heinen V; Nguyen M; Henket M; Sele J; Manise M; Corhay JL; Louis R
Cytokine; 2011 Nov; 56(2):298-304. PubMed ID: 21880505
[TBL] [Abstract][Full Text] [Related]
20. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
